As of Jan 18
| -0.059 / -7.20%|
The 1 analysts offering 12-month price forecasts for Hemispherx Biopharma Inc have a median target of 17.40, with a high estimate of 17.40 and a low estimate of 17.40. The median estimate represents a +2,189.47% increase from the last price of 0.76.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.